Gene One Life Science delays share placement payment to Nov. 26 over US litigation

INO•2026-10-23

Gene One Life Science postponed payment for its KRW 15 billion private placement from Oct. 23 to Nov. 26, 2026, after Revolt Investment Partnership requested more time to review the company’s legal response to a US default judgment involving Inovio.

1. Payment and listing delayed

Gene One Life Science rescheduled delivery and listing of the new shares from Nov. 6 to Dec. 10, 2026. The company is seeking to vacate the US default judgment on procedural and substantive grounds.

Sources

Gene One Life Science delays share placement payment to Nov. 26 over US litigation

Publicnow

Gene One Life Science delays share placement payment to Nov. 26 over US litigation

1. Payment and listing delayed

Related News

Nasdaq trade halt continues; reason not available at 03:58 a.m.

New York cocoa may fall to $5,465

McDonald's India operator Westlife quarterly loss narrows as promotions attract customers

Sources

Gene One Life Science delays share placement payment to Nov. 26 over US litigation

Comcast Corporation: Evercore ISI cuts target price to $29 from $30

Nasdaq trade halt continues; reason not available at 03:58 am